2
Total investments
2
Early stage
0
Mid stage
0
Late stage
26y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jun 2017
State-of-the-art biotechnology company enabling biologically targeted radiotherapy Boron Neutron Capture Therapy (BNCT), a promising, previously inaccessible cancer treatment.
Board Observer
Jan 2000
TAE Technologies (pronounced T-A-E) was founded in 1998 to develop commercial fusion power with the cleanest environmental profile. The company’s pioneering work represents the fastest, most practical, and economically competitive solution to bring abundant clean energy to the grid.
With more than 2,300 patents filed globally and approximately 1,400 granted, more than $1.2 billion in private capital raised, five generations of National Laboratory-scale devices built along with two more in development, and an experienced team of over 600 employees, TAE is now on the cusp of delivering this transformational energy source capable of sustaining the planet for thousands of years. The company’s revolutionary technologies have produced a robust portfolio of commercial innovations in large adjacent markets such as power management, energy storage, electric mobility, fast charging, life sciences, and more. TAE is based in California, and maintains international offices in the UK, EU, and Switzerland. Multidisciplinary and mission-driven by nature, TAE is leveraging proprietary science and engineering to create a bright future.
Experience · 6 entries
All (6)
Investments (2)
Founder (2)
Board (2)
2021
Co-Founder and CFO of MycoMedica Life Sciences
Jan 2021
MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders. We believe that every individual deserves access to quality healthcare and are committed to ensuring that no one is left behind in their pursuit of whole human health.
2017
Board Observer
Jun 2017
State-of-the-art biotechnology company enabling biologically targeted radiotherapy Boron Neutron Capture Therapy (BNCT), a promising, previously inaccessible cancer treatment.
2000
Board Observer
Jan 2000
TAE Technologies (pronounced T-A-E) was founded in 1998 to develop commercial fusion power with the cleanest environmental profile. The company’s pioneering work represents the fastest, most practical, and economically competitive solution to bring abundant clean energy to the grid.
With more than 2,300 patents filed globally and approximately 1,400 granted, more than $1.2 billion in private capital raised, five generations of National Laboratory-scale devices built along with two more in development, and an experienced team of over 600 employees, TAE is now on the cusp of delivering this transformational energy source capable of sustaining the planet for thousands of years. The company’s revolutionary technologies have produced a robust portfolio of commercial innovations in large adjacent markets such as power management, energy storage, electric mobility, fast charging, life sciences, and more. TAE is based in California, and maintains international offices in the UK, EU, and Switzerland. Multidisciplinary and mission-driven by nature, TAE is leveraging proprietary science and engineering to create a bright future.
1998
B
Buchanan Investments, Inc.
Co-Founder & Principal
1998
1994
Executive Director, Head of Asian Equity Sales
Dec 1994
From gaining new experiences in different roles to acquiring fresh knowledge and skills – at UBS we believe that you should never stop growing and learning because life never stops teaching. We know that its our people – with their unique backgrounds, skills, experience levels and interests – who drive our ongoing success. Ready to be part of #teamUBS and make an impact? Find out more at ubs.com/careers.
UBS works with individuals, families, institutions, and corporations around the world to help answer some of lifes questions – whether through award winning wealth management advisory, investment banking and asset management expertise, or private and corporate banking services in Switzerland*. In June 2023, Credit Suisse became a UBS Group company.
With our large and diverse team operating internationally, we have a presence in all major financial centers in more than 50 countries. Although we all come from different backgrounds and specializations, two things unite us: the conviction that we’re stronger together, and the will and curiosity to constantly innovate. That’s the key to us unlocking our full potential (and what we look for in everyone who joins us). It’s also why we’re regularly recognized as an attractive employer.*
* Our awards https://www.ubs.com/awards
Social Media Legal Terms: http://www.ubs.com/social-legal
Show all 6 entries ↓
